<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39432599</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>42</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>COVID-19-induced extracorporeal circulation coagulation during continuous renal replacement therapy: A cross-sectional study.</ArticleTitle><Pagination><StartPage>e40187</StartPage><MedlinePgn>e40187</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e40187</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000040187</ELocationID><Abstract><AbstractText>After the control policies of the COVID-19 epidemic were lifted in China from December 5th, 2022, there was an increase in the demand for hemodialysis and continuous renal replacement therapy (CRRT) at our center, and patients experienced hypercoagulable blood states more frequently. This study aimed to investigate the effect of COVID-19 on extracorporeal coagulation during CRRT. All CRRT records were gathered from the Hemodialysis Center at our hospital from December 5th, 2022 to February 4th, 2023, and analyzed the incidence and risk factors associated with extracorporeal coagulation. COVID-19 substantially increased the likelihood of extracorporeal coagulation during CRRT. Venous pressure and transmembrane pressure were proportional to the severity of extracorporeal coagulation. Additionally, non-tunnel type conduit vascular access, and acute kidney injury had a positive correlation with the severity of coagulation. Blood tests demonstrated that COVID-19 altered 4 coagulation indices. Moreover, mitigation of coagulation can be achieved through increasing the dosage of low molecular weight heparin and administering regional citrate anticoagulation. Patients who fail anticoagulation may be switched to peritoneal dialysis. In conclusion, COVID-19 poses a heightened risk of extracorporeal coagulation during CRRT. This study underscores the importance of anticoagulant treatment in CRRT for infected patients with kidney failure and holds significant implications for clinical practice. In future, the epidemics of COVID-19 or any other pandemic, the metrics in this study can be referenced to determine coagulation risk, as well as relevant therapeutic practices may be considered.</AbstractText><CopyrightInformation>Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Dibin</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Renal Medicine, Peking University Shenzhen Hospital, Peking University, Shenzhen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Guang</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-5271-7079</Identifier><AffiliationInfo><Affiliation>Division of Renal Medicine, Peking University Shenzhen Hospital, Peking University, Shenzhen, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shenzhen Clinical Research Center for Urology and Nephrology, Shenzhen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Shien</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Renal Medicine, Peking University Shenzhen Hospital, Peking University, Shenzhen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Abbas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Nutrition and Health Promotion, University of Home Economics Lahore Pakistan, Lahore, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Renal Medicine, Peking University Shenzhen Hospital, Peking University, Shenzhen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Aihong</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Renal Medicine, Peking University Shenzhen Hospital, Peking University, Shenzhen, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000079664" MajorTopicYN="Y">Continuous Renal Replacement Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="Y">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005112" MajorTopicYN="N">Extracorporeal Circulation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001777" MajorTopicYN="N">Blood Coagulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>22</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>22</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>14</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39432599</ArticleId><ArticleId IdType="pmc">PMC11495713</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000040187</ArticleId><ArticleId IdType="pii">00005792-202410180-00015</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li M, Wu X, Shi J, Niu Y. Endothelium dysfunction and thrombosis in COVID-19 with type 2 diabetes. Endocrine. 2023;82:15–27.</Citation><ArticleIdList><ArticleId IdType="pubmed">37392341</ArticleId></ArticleIdList></Reference><Reference><Citation>Tessema AG, Mengiste ZM, Hundie TG, et al. . The effect of anti-coagulation dosage on the outcome of hospitalized COVID-19 patients in Ethiopia: a multi-center retrospective cohort study. BMC Pulm Med. 2023;23:85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10010242</ArticleId><ArticleId IdType="pubmed">36915064</ArticleId></ArticleIdList></Reference><Reference><Citation>Khadzhynov D, von dem Berge U, Muench F, et al. . Efficacy and complications of regional citrate anticoagulation during continuous renal replacement therapy in critically ill patients with COVID-19. J Crit Care. 2022;67:126–31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576341</ArticleId><ArticleId IdType="pubmed">34768173</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudusinghe D, Riddell A, Gandhi T, Chowdary P, Davenport A. Increased risk of dialysis circuit clotting in hemodialysis patients with COVID-19 is associated with elevated FVIII, fibrinogen and D-dimers. Hemodial Int. 2023;27:38–44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9537782</ArticleId><ArticleId IdType="pubmed">36081392</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang G, Shan H, Wu D, et al. . COVID-19 increases extracorporeal coagulation during hemodialysis associated with upregulation of vWF/FBLN5 signaling in patients with severe/critical symptoms. BMC Infect Dis. 2024;24:427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11036607</ArticleId><ArticleId IdType="pubmed">38649864</ArticleId></ArticleIdList></Reference><Reference><Citation>Macedo E, Mehta RL. Continuous dialysis therapies: core curriculum 2016. Am J Kidney Dis. 2016;68:645–57.</Citation><ArticleIdList><ArticleId IdType="pubmed">27241853</ArticleId></ArticleIdList></Reference><Reference><Citation>Borbolla-Flores P, Villegas-Gutiérrez LY, Samaniego-Segovia BM, et al. . Critically ill patients with COVID-19 pneumonia requiring continuous renal replacement therapy with oXiris® membrane in a third-level hospital in Northeast Mexico. Blood Purif. 2024;53:634–40.</Citation><ArticleIdList><ArticleId IdType="pubmed">38934142</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliva I, Ferré C, Daniel X, et al. . Risk factors and outcome of acute kidney injury in critically ill patients with SARS-CoV-2 pneumonia: a multicenter study. Med Intensiva (Engl Ed). 2024;S2173-5727(24)00176-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">39003118</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh S, Banerjee M, Chattopadhyay AK. Effect of vaccine dose intervals: considering immunity levels, vaccine efficacy, and strain variants for disease control strategy. PLoS One. 2024;19:e0310152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11412640</ArticleId><ArticleId IdType="pubmed">39298500</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Z, Wang Y, Bai Y, Wang L, Cowling BJ, Meyers LA. Estimate of COVID-19 deaths, China, December 2022-February 2023. Emerg Infect Dis. 2023;29:2121–24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10521589</ArticleId><ArticleId IdType="pubmed">37640373</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang G, Tan L, Yao H, Xiong Z, Wu J, Huang X. Long-term effects of severe burns on the kidneys: research advances and potential therapeutic approaches. J Inflamm Res. 2023;16:1905–21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10162109</ArticleId><ArticleId IdType="pubmed">37152866</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y, Huang X, Shan Y, et al. . The difference in diameter between radial artery and cephalic vein correlates with primary patency of radio-cephalic arteriovenous fistula. J Vasc Access. 2024;25:914–21.</Citation><ArticleIdList><ArticleId IdType="pubmed">36517946</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y, Huang H, Liao Y, et al. . Risk factors affecting the sleep quality of patients on dialysis: a single-center cross-sectional study. Medicine (Baltim). 2024;103:e37577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10977595</ArticleId><ArticleId IdType="pubmed">38552063</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Wang A, Sui W, Khan A, Xiong Z, Yang G. Involuntary falls in patients with chronic kidney diseases on nephrology wards: research advances and future perspectives. Nurs Res Rev. 2024;Volume 14:69–80.</Citation></Reference><Reference><Citation>Jin H, Fang W, Wang L, et al. . A randomized controlled trial comparing automated peritoneal dialysis and hemodialysis for urgent-start dialysis in ESRD. Kidney Int Rep. 2024;9:2627–34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11403029</ArticleId><ArticleId IdType="pubmed">39291207</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinnakirouchenan R, Holley JL. Peritoneal dialysis versus hemodialysis: risks, benefits, and access issues. Adv Chronic Kidney Dis. 2011;18:428–32.</Citation><ArticleIdList><ArticleId IdType="pubmed">22098661</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai T, Cao S, Yang X. [Comparison of clinical efficacy between continuous renal replacement therapy and intermittent haemodialysis for the treatment of sepsis-induced acute kidney injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016;28:277–80.</Citation><ArticleIdList><ArticleId IdType="pubmed">29919984</ArticleId></ArticleIdList></Reference><Reference><Citation>Fathima N, Kashif T, Janapala RN, Jayaraj JS, Qaseem A. Single-best choice between intermittent versus continuous renal replacement therapy: a review. Cureus. 2019;11:e5558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6820322</ArticleId><ArticleId IdType="pubmed">31695978</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuett K, Savvaidis A, Maxeiner S, et al. . Clot structure: a potent mortality risk factor in patients on hemodialysis. J Am Soc Nephrol. 2017;28:1622–30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5407718</ArticleId><ArticleId IdType="pubmed">28057772</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Mario F, Regolisti G, Di Maria A, et al. . Sustained low-efficiency dialysis with regional citrate anticoagulation in critically ill patients with COVID-19 associated AKI: a pilot study. J Crit Care. 2021;63:22–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857061</ArticleId><ArticleId IdType="pubmed">33611151</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold F, Westermann L, Rieg S, et al. . Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study. BMC Nephrol. 2020;21:486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7668013</ArticleId><ArticleId IdType="pubmed">33198670</ArticleId></ArticleIdList></Reference><Reference><Citation>Altarawneh HN, Chemaitelly H, Ayoub HH, et al. . Protective effect of previous SARS-CoV-2 infection against omicron BA.4 and BA.5 subvariants. N Engl J Med. 2022;387:1620–2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9559315</ArticleId><ArticleId IdType="pubmed">36198139</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezerra R, Feitosa ADM, Silvestre OM, et al. . Dialysis parameters associated with SARS-CoV-2 infection and prognosis in end-stage kidney disease. Ann Med. 2024;56:2343890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11095274</ArticleId><ArticleId IdType="pubmed">38738416</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagnosis and treatment protocol for COVID-19 patients (Trial Version 10). 2022.</Citation></Reference><Reference><Citation>Zuo L. Standard Manual of Hemodialysis Treatment (Chinese Edition). 2016.</Citation></Reference><Reference><Citation>An J-H, Qi F-R, Cheng X-Y, et al. . Dynamic characteristics of blood platelet count in COVID-19 patients. J Biomater Tissue Eng. 2022;12:778–87.</Citation></Reference><Reference><Citation>Shrivastava S, Hunt BJ, Dorling A. Coagulopathies in chronic kidney disease. In: Goldsmith DJ, Turner NN, Turner NN, Lameire N, Goldsmith DJ, Winearls CG, et al.., eds. Oxford Textbook of Clinical Nephrology: Three-Volume Pack. Oxford University Press. 2015;0.</Citation></Reference><Reference><Citation>Tian Y, Pan T, Wen X, et al. . Efficacy and safety of direct oral anticoagulants compared with heparin for preventing thromboembolism in hospitalized patients with COVID-19: a systematic review and meta-analysis. Clin Appl Thromb Hemost. 2023;29:10760296231164355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10170187</ArticleId><ArticleId IdType="pubmed">37131319</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, et al. . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Guan X, Wu P, et al. . Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199–207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7121484</ArticleId><ArticleId IdType="pubmed">31995857</ArticleId></ArticleIdList></Reference><Reference><Citation>Montopoli M, Zumerle S, Vettor R, et al. . Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532). Ann Oncol. 2020;31:1040–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7202813</ArticleId><ArticleId IdType="pubmed">32387456</ArticleId></ArticleIdList></Reference><Reference><Citation>Canas LS, Sudre CH, Capdevila Pujol J, et al. . Early detection of COVID-19 in the UK using self-reported symptoms: a large-scale, prospective, epidemiological surveillance study. Lancet Digit Health. 2021;3:e587–98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8321433</ArticleId><ArticleId IdType="pubmed">34334333</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzoor T, Saleem A, Farooq N, et al. . Extracellular vesicles derived from mesenchymal stem cells - a novel therapeutic tool in infectious diseases. Inflamm Regen. 2023;43:17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9970864</ArticleId><ArticleId IdType="pubmed">36849892</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang G, Chu PL, Rump LC, Le TH, Stegbauer J. ACE2 and the homolog collectrin in the modulation of nitric oxide and oxidative stress in blood pressure homeostasis and vascular injury. Antioxid Redox Signal. 2017;26:645–59.</Citation><ArticleIdList><ArticleId IdType="pubmed">27889958</ArticleId></ArticleIdList></Reference><Reference><Citation>Minami T, Iwata Y, Wada T. Renal complications in coronavirus disease 2019: a systematic review. Inflamm Regen. 2020;40:31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7735801</ArticleId><ArticleId IdType="pubmed">33317643</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang G, Waheed S, Wang C, Shekh M, Li Z, Wu J. Exosomes and their bioengineering strategies in the cutaneous wound healing and related complications: current knowledge and future perspectives. Int J Biol Sci. 2023;19:1430–54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10086759</ArticleId><ArticleId IdType="pubmed">37056923</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hove S, Werion A, Anantharajah A, Belkhir L, van Dievoet MA, Hantson P. Streptococcus pneumoniae bacteremia with acute kidney injury and transient ADAMTS13 deficiency. Case Rep Infect Dis. 2023;2023:1–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10163968</ArticleId><ArticleId IdType="pubmed">37159753</ArticleId></ArticleIdList></Reference><Reference><Citation>Olayemi G, Oferczak M, Elagizi A, El-Abbassi I, Eschete M, Crowe J. Gonococcal endocarditis: the gift that stops giving! An uncommon presentation of a common disease. J La State Med Soc. 2017;169:47.</Citation><ArticleIdList><ArticleId IdType="pubmed">28414664</ArticleId></ArticleIdList></Reference><Reference><Citation>Lichota A, Gwozdzinski K, Kowalczyk E, Kowalczyk M, Sienkiewicz M. Contribution of staphylococcal virulence factors in the pathogenesis of thrombosis. Microbiol Res. 2024;283:127703.</Citation><ArticleIdList><ArticleId IdType="pubmed">38537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirijatuphat R, Rungrotsakhon A, Leelaporn A. Clinical characteristics and outcomes of acute bacterial meningitis in adults at a tertiary university hospital in Thailand. Medicine (Baltim). 2024;103:e37301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10883623</ArticleId><ArticleId IdType="pubmed">38394527</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson DL, Coke L, Zhang SX, et al. . Myocarditis and brain abscess caused by disseminated Scedosporium boydii infection. J Natl Med Assoc. 2024;116:238–46.</Citation><ArticleIdList><ArticleId IdType="pubmed">38310044</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoumann WM, Hegazy AA, Nafae RM, et al. . Use of ivermectin as a potential chemoprophylaxis for COVID-19 in Egypt: a randomised clinical trial. J Clin Diagn Res. 2021;15:27–32.</Citation></Reference><Reference><Citation>Hegazy AA. Ivermectin for COVID-19 prophylaxis. Eur J Clin Exp Med. 2021;19:280–82.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>